Total Other Income - Xeris Biopharma Holdings Inc (NASDAQ:XERS) - Alpha Spread

Xeris Biopharma Holdings Inc
NASDAQ:XERS

Watchlist Manager
Xeris Biopharma Holdings Inc Logo
Xeris Biopharma Holdings Inc
NASDAQ:XERS
Watchlist
Price: 2.965 USD -0.5% Market Closed
Market Cap: 439.6m USD
Have any thoughts about
Xeris Biopharma Holdings Inc?
Write Note

Xeris Biopharma Holdings Inc
Total Other Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Xeris Biopharma Holdings Inc
Total Other Income Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Total Other Income Analysis
Latest Figures & CAGR of Competitors

Company Total Other Income CAGR 3Y CAGR 5Y CAGR 10Y
Xeris Biopharma Holdings Inc
NASDAQ:XERS
Total Other Income
$7.1m
CAGR 3-Years
N/A
CAGR 5-Years
47%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Total Other Income
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bristol-Myers Squibb Co
NYSE:BMY
Total Other Income
-$115m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pfizer Inc
NYSE:PFE
Total Other Income
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Merck & Co Inc
NYSE:MRK
Total Other Income
$866m
CAGR 3-Years
18%
CAGR 5-Years
62%
CAGR 10-Years
-3%
Eli Lilly and Co
NYSE:LLY
Total Other Income
$460.3m
CAGR 3-Years
-22%
CAGR 5-Years
8%
CAGR 10-Years
16%

See Also

What is Xeris Biopharma Holdings Inc's Total Other Income?
Total Other Income
7.1m USD

Based on the financial report for Jun 30, 2024, Xeris Biopharma Holdings Inc's Total Other Income amounts to 7.1m USD.

What is Xeris Biopharma Holdings Inc's Total Other Income growth rate?
Total Other Income CAGR 5Y
47%

Over the last year, the Total Other Income growth was 5%.

Back to Top